Janugriptin 25 mg Tablet (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 28.34mg
Tablet · Prescription medication
Sears Pharmaceutical Co., Ltd.
MFDS item code 202108141 · Approved 2021.12.29
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to aid blood sugar control in patients with type 2 diabetes. It can be used alone or in combination with dietary and exercise therapy, and in cases where blood sugar control is difficult during initial treatment, it can be taken together with Metformin. It can also enhance blood sugar control when combined with various diabetes medications such as sulfonylureas, thiazolidinediones, and insulin. This helps in effectively controlling blood sugar with a combination of various treatment methods. Therefore, this medication is used to improve blood sugar control in patients with type 2 diabetes.
For monotherapy or combination therapy, administer this medicine at a dose of 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (eGFR ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (eGFR ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (eGFR ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (eGFR < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.
This medication may cause serious allergic reactions in some patients. These reactions may occur within 3 months after starting the medication, so caution is required. If symptoms such as rash, difficulty breathing, or swelling of the face or neck occur, discontinue the medication immediately and consult a doctor. During the use of this medication, signs of pancreatitis, which is inflammation of the pancreas, may appear, so symptoms such as abdominal pain, nausea, and vomiting should be closely monitored. If pancreatitis is suspected, discontinue the medication immediately and inform healthcare professionals. This medication is not for use in patients with type 1 diabetes or diabetic ketoacidosis. Patients allergic to this medication or its components should not take it. For patients with reduced kidney function, excretion of this medication may be slower, requiring dosage adjustments, and regular kidney function tests are important. In clinical trials, this medication has been shown to cause hypoglycemic episodes when used in conjunction with other blood sugar-lowering agents, so caution is needed when used with insulin or sulfonylureas. Side effects such as headache, upper respiratory tract infection, nasopharyngitis, diarrhea, abdominal pain, nausea, etc. have been reported during the use of this medication, and if symptoms are severe, consultation with healthcare professionals is recommended. This medication is not recommended for pregnant women, and breastfeeding women should also avoid taking this medication. Safety and efficacy have not been established in children or adolescents under 18 years old, so its use is not recommended. Elderly patients may have reduced kidney function, requiring dosage adjustments and kidney function tests. In case of overdose, gastrointestinal decontamination and monitoring through ECG may be required, and blood dialysis may be needed to eliminate the medication if necessary. If new symptoms or abnormal reactions occur during the use of this medication, inform the doctor immediately.
Severe allergic reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, exfoliative skin disease, acute pancreatitis, hypoglycemia, upper respiratory tract infections, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, peripheral edema, constipation, vomiting, arthralgia accompanied by severe and disabling conditions, bullous-like pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased blood triglycerides, gastritis, increased low-density lipoprotein, hyperglycemia, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering. It is important to maintain a storage temperature between 1 degree Celsius and 30 degrees Celsius to keep the medication effective for a longer period.
Bright yellow-orange round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 28.34mg
Tablet · Prescription medication
Sears Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.